Aripiprazole Tablet
Product Images NDC 33342-125

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 33342-125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg-100s (Aripiprazole 10mg 10x10s)

The image shows the label for Aripiprazole Tablets, USP 10 mg, oral tablets manufactured by Macleods Pharmaceuticals Limited and Macleods Pharma USA, Inc. The package contains 100 tablets (10 x 10 unit dose) and includes storage instructions and a note that the unit-dose package is not child-resistant. The label also features the product's NDC number 33342-124-12 and a barcode.*

FDA Label Image

10mg-30s (Aripiprazole 10mg 30s)

Label for Aripiprazole Tablets, USP 10 mg oral tablets by Macleods Pharmaceuticals Limited. The label states each tablet contains 10 mg Aripiprazole and includes storage instructions (20° to 25°C with permitted excursions). It is for a bottle of 30 tablets, manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. in India. The label includes NDC 33342-124-07 and a pharmacist dispensing note.*

FDA Label Image

15mg-100s (Aripiprazole 15mg 10x10s)

Packaging label for Aripiprazole Tablets, USP 15 mg by Macleods Pharmaceuticals Limited. The label includes the product name, strength of 15 mg, quantity of 100 tablets (10 x 10 unit dose), and storage instructions. It also identifies the manufacturer as Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., India. The label features a barcode and notes that this is a unit-dose package not child-resistant.*

FDA Label Image

15mg-30s (Aripiprazole 15mg 30s)

Aripiprazole Tablets USP 15 mg oral tablets label from Macleods Pharmaceuticals Limited. The label states each tablet contains 15 mg Aripiprazole, USP, and instructs the pharmacist to dispense the Medication Guide to each patient. It shows storage conditions and manufacturing details for Macleods Pharma USA and Macleods Pharmaceuticals Ltd India. The package contains 30 tablets.*

FDA Label Image

20mg-100s (Aripiprazole 20mg 10x10s)

Label for Aripiprazole Tablets, USP 20 mg oral tablets by Macleods Pharmaceuticals Limited. Packaging indicates 100 tablets (10 x 10 unit doses). Manufactured for Macleods Pharma USA, Inc., Plainsboro, NJ, with manufacturing in Baddi, Himachal Pradesh, India. Includes storage instructions and a note that the unit-dose package is not child-resistant.*

FDA Label Image

20mg-30s (Aripiprazole 20mg 30s)

Aripiprazole Tablets, USP 20 mg oral tablets label showing the product name, strength, dosage form, and package size of 30 tablets. The label includes the manufacturer's information: Macleods Pharma USA, Inc., and Macleods Pharmaceuticals Ltd. Storage instructions and a pharmacist dispensing note are also visible.*

FDA Label Image

2mg-100s (Aripiprazole 2mg 10x10s)

Packaging label for Aripiprazole Tablets USP 2 mg oral tablets by Macleods Pharmaceuticals Limited. The unit-dose carton contains 100 tablets (10 x 10 unit doses) with storage and dosage information. Manufactured in Baddi, Himachal Pradesh, India for Macleods Pharma USA, Inc.*

FDA Label Image

2mg-30s (Aripiprazole 2mg 30s)

Aripiprazole Tablets USP 2 mg tablet label from Macleods Pharmaceuticals Limited. The label includes dosage strength 2 mg, a count of 30 tablets, storage instructions (20° to 25°C with permitted excursions), and manufacturing details from Macleods Pharma USA and Macleods Pharmaceuticals Ltd., India. Barcode and code HP/152/07 are also visible.*

FDA Label Image

30mg-100s (Aripiprazole 30mg 10x10s)

Packaging label for Aripiprazole Tablets, USP 30 mg by Macleods Pharmaceuticals Limited. The label shows the product name with strength 30 mg prominently displayed multiple times, listing 100 tablets packaged as 10 x 10 unit doses. It includes manufacturer information for Macleods Pharma USA, Inc., and Macleods Pharmaceuticals Ltd. storage instructions specify 20° to 25°C with permitted excursions. The label states the product is Rx only and not child-resistant.*

FDA Label Image

30mg-30s (Aripiprazole 30mg 30s)

Label for Aripiprazole Tablets, USP 30 mg by Macleods Pharmaceuticals Limited. The oral tablet packaging indicates a 30-tablet count. It includes storage instructions, dosage advice to consult prescribing information, and notes the product is manufactured for Macleods Pharma USA and by Macleods Pharmaceuticals Ltd in India.*

FDA Label Image

5mg-100s (Aripiprazole 5mg 10x10s)

Packaging label for Aripiprazole Tablets, USP 5 mg by Macleods Pharmaceuticals Limited. The label indicates a unit-dose package containing 100 tablets (10 x 10 dose units). It includes storage instructions and mentions the product is not child-resistant. The label displays the manufacturer details including Macleods Pharma USA and Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India.*

FDA Label Image

5mg-30s (Aripiprazole 5mg 30s)

Label for Aripiprazole Tablets, USP 5 mg by Macleods Pharmaceuticals Limited. The oral tablet packaging indicates 30 tablets per container. The label includes storage instructions, barcode, and notes that the medication is prescription only. Manufacturer details list Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd.*

FDA Label Image

Fig1 (Aripiprazole Fig 1)

A chart titled "Effect of Other Drugs on Aripiprazole" showing the fold change and 90% confidence interval of Aripiprazole's pharmacokinetic parameters (AUC and Cmax) when coadministered with various drugs. The x-axis represents the change relative to reference (without interacting drug). Different inhibitors, inducers, and other drugs such as ketoconazole, quinidine, carbamazepine, famotidine, valproate, lithium, and lorazepam are listed on the y-axis.*

FDA Label Image

Fig2 (Aripiprazole Fig 2)

A pharmacokinetic chart illustrating the effect of other drugs on the metabolism of Aripiprazole's active metabolite, Dehydro-Aripiprazole. The graph shows fold changes in pharmacokinetic parameters AUC and Cmax relative to a reference without interacting drugs, for various inhibitors, inducers, and other drugs such as ketoconazole, quinidine, carbamazepine, famotidine, valproate, lithium, and lorazepam.*

FDA Label Image

Fig3 (Aripiprazole Fig 3)

A pharmacokinetic forest plot showing fold change and 90% confidence intervals of various drugs/metabolites relative to a reference without interacting drug. The X-axis represents change relative to reference from 0.5 to 3.0, measuring parameters such as DM/DRP, AUC, and Cmax for substances including dextromethorphan, warfarin (S- and R-), omeprazole, lamotrigine, valproate, lithium, lorazepam, venlafaxine, and O-desmethylvenlafaxine.*

FDA Label Image

Fig4 (Aripiprazole Fig 4)

A pharmacokinetic chart titled 'Aripiprazole Fold Change and 90% CI' depicting the changes in AUC and Cmax relative to reference for special populations, including CYP2D6 metabolizer status, gender, age groups, hepatic impairment levels, and severe renal impairment. The chart uses error bars to display fold changes and confidence intervals across these categories.*

FDA Label Image

Fig5 (Aripiprazole Fig 5)

A forest plot chart titled 'Dehydro-Aripiprazole Fold Change and 90% CI' illustrating the changes in AUC and Cmax values relative to reference for various factors including CYP2D6 metabolizer status, gender, age groups, hepatic impairment severities, and severe renal impairment. The X-axis represents the fold change relative to reference, while the Y-axis lists the factors compared. Data points are presented with confidence intervals.*

FDA Label Image

Fig6 (Aripiprazole Fig 6)

A Kaplan-Meier survival curve comparing the proportion of subjects with relapse over days from randomization between Aripiprazole (blue solid line) and placebo (red dashed line). The x-axis represents days from randomization (0 to 182), and the y-axis represents the proportion with relapse (0.0 to 1.0). Below the x-axis is a table indicating the number of subjects at risk for each group over time.*

FDA Label Image

Str (Aripiprazole Str)

Chemical structure of Aripiprazole, depicted as a molecular formula showing its atomic connections, including rings and functional groups relevant to its composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.